Outcome of Board Meeting held on 05.08.2025 for considering financial result of June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited standalone financial results for Q1 FY26 (quarter ended June 30, 2025). Total income rose to ₹444.45 lakhs from ₹71.24 lakhs in Q1 FY25, but the company swung to a loss of ₹69.52 lakhs at the PAT level compared to a profit of ₹99.06 lakhs in the year-ago quarter. Basic EPS turned negative at ₹(0.13). The Board also reconstituted all committees. Notably, the company vacated its Mira Road hospital and now only provides diagnostic and pharmacy services via tie-ups. The statutory auditor flagged several concerns: an eviction suit at the Mahim division where ₹368 lakhs was ordered to be deposited but wasn't (resulting in attachment of movable properties), unpaid MSME vendor interest, overdue Profession Tax of ₹1.33 lakhs, and unverifiable prior-period expenses of ₹16.5 lakhs. The auditor did not qualify its review conclusion but drew attention to these matters.
Mixed-to-negative for shareholders — despite higher income, the company slipped back into loss, and serious red flags emerged including property attachment risks, regulatory penalties (SEBI show-cause notice dated June 3, 2025), and shrinking core operations. Stock price may come under pressure given the operational contraction and unresolved legal exposures.